Importance of taking into consideration new and traditional treatment options for CLL patients
Prognostic markers for CLL - how do they help determine who gets which treatment?
Remission maintenance with histamine dihydrochloride (HDC)/IL-2 therapy in AML
iwCLL – International Workshop on Chronic Lymphocytic Leukemia
Federico Caligaris-Cappio et al.
Double hit lymphoma: a challenge for lymphoma experts